Novo Nordisk A/S
Drug Manufacturers—General·Bagsværd, Denmark·$33.0B·NYSE: NVO
Novo Nordisk is a global healthcare company and the world leader in diabetes care, also known for Ozempic and Wegovy weight-loss treatments.
HEADQUARTERSBagsværd
CEOLars Fruergaard Jørgensen
SECTORHealthcare
EMPLOYEES60,000
IPO DATE1923
Active in: